NEW YORK (GenomeWeb News) — MorphoSys said today that Proteomika, a proteomics biomarker-discovery subsidiary of Progenika Biopharma, has ordered “multiple” research antibodies from its AbD Serotec business unit.
 
The agreement places Proteomika “among the largest customers for custom monoclonals services provided by AbD Serotec,” MorphoSys said, but did not disclose financial details.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genome-wide association study highlights a potential role for hair follicles in acne risk, according to New Scientist.

Newsday reports that breast cancer genetic testing guidelines for are out of date and may miss individuals.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.